XML 93 R83.htm IDEA: XBRL DOCUMENT v3.23.2
Capital Stock and Reserves - Additional Information (Details)
$ / shares in Units, $ / shares in Units, $ in Thousands, ¥ in Millions, $ in Millions
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jan. 31, 2023
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
$ / shares
shares
Jun. 30, 2022
HKD ($)
$ / shares
shares
Dec. 31, 2022
shares
Jun. 30, 2023
CNY (¥)
shares
Jun. 06, 2023
shares
Jun. 23, 2022
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Share-based compensation costs recorded for the period | $   $ 6,800 $ 7,600 $ 11,900 $ 13,700          
Stock-based compensation expense | $   $ 6,823 $ 7,637 $ 11,882 $ 13,689          
Maximum number of shares of common stock may be issued for outstanding PSU   54,620,083   54,620,083     54,148,614 54,620,083    
Common shares purchased in open market by trustee in connection with RSUs   0 0 0 0 0        
Number of treasury shares held in trust for future settlement of share based awards       0     0      
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units   2,868,749 4,557,526 3,379,371 6,302,818 6,302,818        
Percentage of statutory net profits to statutory surplus reserve to be appropriated   10.00%   10.00%       10.00%    
Discontinuation of contribution, Aggregate sum of statutory surplus reserve more than its registered capital,percent.   50.00%   50.00%       50.00%    
Statutory surplus reserve appropriated   $ 5,600   $ 5,600       ¥ 36.4    
Statutory surplus reserve to its subsidiaries registered capital percent   50.00%   50.00%       50.00%    
IMAX China                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Details of the share repurchase program       In 2022, IMAX China's shareholders granted its Board of Directors a general mandate authorizing the Board, subject to applicable laws, to repurchase shares of IMAX China not to exceed 10% of the total number of issued shares as of June 23, 2022 (34,063,480 shares). This program expired on the date of the 2023 Annual General Meeting of IMAX China on June 6, 2023. During the 2023 Annual General Meeting, shareholders approved the repurchase of shares of IMAX China not to exceed 10% of the total number of shares as of June 6, 2023 (33,959,314 shares). While this program would have been valid until the 2024 Annual General Meeting of IMAX China, pursuant to the transaction described in Note 18 — Subsequent Event, IMAX China will not execute any additional share repurchases. The repurchases may be made in the open market or through other means permitted by applicable laws. IMAX China has no obligation to repurchase its shares and the share repurchase program may be suspended or discontinued by IMAX China at any time.            
Stock Repurchase Program Expiration Date       Jun. 06, 2023     Jun. 23, 2022      
Repurchase of common shares   0 0 0 1,448,000 1,448,000        
Stock Acquired, Average Cost per Share | (per share)         $ 1.26 $ 9.89        
Change in ownership interest related to IMAX China common share repurchases         $ 1,800 $ 14.3        
Stock Repurchase Program, maximum percentage of shares to be repurchased                 10.00% 10.00%
Stock Repurchase Program, Authorized number of shares                 33,959,314 34,063,480
Parent [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Details of the share repurchase program       In 2023, the Company’s Board of Directors approved a 36-month extension to its share repurchase program through June 30, 2026. The Company’s total share repurchase authority is $400.0 million under the current share repurchase program. As of June 30, 2023, the Company has $191.5 million available under the repurchased program. The repurchases may be made either in the open market or through private transactions, including repurchases made pursuant to a plan intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, subject to market conditions, applicable legal requirements, and other relevant factors. The Company has no obligation to repurchase shares and the share repurchase program may be suspended or discontinued by the Company at any time.            
Stock Repurchase Program, Authorized Amount | $   $ 191,500   $ 191,500            
Stock Repurchase Program Expiration Date       Jun. 30, 2026            
Repurchase of common shares 140,000 21,024 2,702,548 130,501 3,083,200 3,083,200        
Stock Acquired, Average Cost per Share | $ / shares $ 14.45 $ 16.89 $ 15.92 $ 15.20 $ 15.99          
Change in ownership interest related to IMAX China common share repurchases | $ $ 2,000 $ 400 $ 43,000 $ 2,000 $ 49,300          
Parent [Member] | Maximum [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock Repurchase Program, Authorized Amount | $   400,000   400,000            
Non-controlling Interests [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Change in ownership interest related to IMAX China common share repurchases | $         1,301          
Restricted Share Units [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock-based compensation expense | $   $ 3,829 $ 4,478 $ 7,194 $ 7,889          
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units   23,122 775,191 10,765 1,408,956 1,408,956        
Restricted Share Units [Member] | Non Employee [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock-based compensation expense | $   $ 1,700 $ 1,300 $ 1,700 $ 1,300          
Employee Stock Option [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock-based compensation expense | $     $ 122 $ 84 $ 329          
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units   2,812,821 3,607,391 3,335,800 3,607,391 3,607,391        
Performance Stock Units [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock-based compensation expense | $   $ 2,001 $ 1,724 $ 2,925 $ 3,453          
Stock based awards vesting period       3 years            
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage       175.00%            
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units   32,806 174,944 32,806 1,286,471 1,286,471        
Performance Stock Units [Member] | Minimum [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage       0.00%            
Performance Stock Units [Member] | Maximum [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage       175.00%            
Performance Stock Units [Member] | EBITDA | Maximum [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Maximum number of shares of common stock may be issued for outstanding PSU   1,605,621   1,605,621       1,605,621